Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
807K
-
Shares change
-
+613K
-
Total reported value, excl. options
-
$1.66M
-
Value change
-
+$930K
-
Number of buys
-
13
-
Number of sells
-
-3
-
Price
-
$2.06
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q4 2018
20 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q4 2018.
Altimmune, Inc. - Common Stock (ALT) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 807K shares
of 80.7M outstanding shares and own 1% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (238K shares), RENAISSANCE TECHNOLOGIES LLC (195K shares), Vanguard Group Inc (110K shares), OXFORD ASSET MANAGEMENT LLP (84.9K shares), DIMENSIONAL FUND ADVISORS LP (61.9K shares), BANK OF MONTREAL /CAN/ (40K shares), Virtu Financial LLC (16.3K shares), GEODE CAPITAL MANAGEMENT, LLC (16.1K shares), D. E. Shaw & Co., Inc. (13.1K shares), and TWO SIGMA INVESTMENTS, LP (12.5K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.